Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hahn

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Urologic Oncology|May 20, 2025
Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era-Real world experiences from a multi-institutional cohortBenedikt Hoeh, Cristina Cano Garcia, Angelika Mattigk, et al.
Scientific Reports|December 5, 2018
Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate CancerTobias Lange, Su Jung Oh-Hohenhorst, Simon A Joosse, et al.
Clinical Genitourinary Cancer|June 2, 2024
First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From GermanyCristina Cano Garcia, Benedikt Hoeh, Subhajit Mandal, et al.
Urologia Internationalis|December 24, 2024
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional CohortAngelika Mattigk, Cristina Cano Garcia, Niklas Klümper, et al.
Clinical & Translational Immunology|October 30, 2023
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitionsBenedikt Hoeh, Cristina Cano Garcia, Severine Banek, et al.
Nature Biotechnology|April 27, 2023
Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissuesViktoria Wagner, Fabian Kern, Oliver Hahn, et al.
Cell|November 5, 2025
Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic statesNikolai P Jaschke, Joseph R Luchsinger, Zuojia Chen, et al.
Scientific Reports|April 18, 2026
Combined elevation of pre-treatment γ-glutamyltransferase and lactate dehydrogenase as independent prognosticator for metastatic renal cell carcinoma undergoing immune-based therapyAnnemarie Uhlig, Angelika Mattigk, Marcus Sondermann, et al.
Elife|March 19, 2021
Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in <i>Drosophila</i>Magda L Atilano, Sebastian Grönke, Teresa Niccoli, et al.
Cell Metabolism|July 7, 2017
The Sense of Smell Impacts Metabolic Health and ObesityCeline E Riera, Eva Tsaousidou, Jonathan Halloran, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Urologic Oncology|May 20, 2025
Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era-Real world experiences from a multi-institutional cohortBenedikt Hoeh, Cristina Cano Garcia, Angelika Mattigk, et al.
Scientific Reports|December 5, 2018
Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate CancerTobias Lange, Su Jung Oh-Hohenhorst, Simon A Joosse, et al.
Clinical Genitourinary Cancer|June 2, 2024
First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From GermanyCristina Cano Garcia, Benedikt Hoeh, Subhajit Mandal, et al.
Urologia Internationalis|December 24, 2024
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional CohortAngelika Mattigk, Cristina Cano Garcia, Niklas Klümper, et al.
Clinical & Translational Immunology|October 30, 2023
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitionsBenedikt Hoeh, Cristina Cano Garcia, Severine Banek, et al.
Nature Biotechnology|April 27, 2023
Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissuesViktoria Wagner, Fabian Kern, Oliver Hahn, et al.
Cell|November 5, 2025
Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic statesNikolai P Jaschke, Joseph R Luchsinger, Zuojia Chen, et al.
Scientific Reports|April 18, 2026
Combined elevation of pre-treatment γ-glutamyltransferase and lactate dehydrogenase as independent prognosticator for metastatic renal cell carcinoma undergoing immune-based therapyAnnemarie Uhlig, Angelika Mattigk, Marcus Sondermann, et al.
Elife|March 19, 2021
Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in <i>Drosophila</i>Magda L Atilano, Sebastian Grönke, Teresa Niccoli, et al.
Cell Metabolism|July 7, 2017
The Sense of Smell Impacts Metabolic Health and ObesityCeline E Riera, Eva Tsaousidou, Jonathan Halloran, et al.
Pageof 9